Table 4 difference in laboratory investigations between the two groups
| Â | COVID-19 patients with chronic chest N = 57 | C0VID-19 patients without chronic chest N = 266 | p-value |
|---|---|---|---|
N % | N % | ||
TLC | |||
 < 4000 | 52 (91.2%) | 242 (91.7%) | 0.914 |
 • ≥ 4000 | 5 (8.8%) | 24 (9.02%) |  |
Lymphocytes | |||
 • < 1000 | 34 (59.6%) | 168 (63.1%) | 0.42 |
 • ≥ 1000 | 23 (40.4%) | 98 (36.8%) |  |
CRP | |||
 • ≤ 10 | 2 (3.5%) | 8 (3.1%) | 0.605 |
 • > 10 | 55 (96.5%) | 258 (96.9%) |  |
D-dimer | |||
 • ≤ 0.5 | 23 (40.4%) | 70 (26.3%) | 0.033* |
 • > 0.5 | 34 (59.6%) | 196 (73.7%) |  |
Ferritin | |||
 • ≤ 360 | 27 (47.4%) | 43 (16.1%) | < 0.0001* |
 • > 360 | 30 (52.6%) | 223 (83.8%) |  |
LDH | |||
 • ≤ 280 | 13 (23.6%) | 30 (11.2%) | 0.008* |
 • > 280 | 42 (76.4%) | 236 (88.7%) |  |